Applied DNA Sciences, Inc. (NASDAQ:APDN – Free Report) shares are going to reverse split on Thursday, April 25th. The 1-20 reverse split was announced on Thursday, April 25th. The number of shares owned by shareholders will be adjusted after the market closes on Thursday, April 25th.
Applied DNA Sciences Stock Performance
Shares of Applied DNA Sciences stock traded down $0.04 during midday trading on Tuesday, reaching $0.29. 811,420 shares of the company’s stock traded hands, compared to its average volume of 116,854. The company has a market cap of $4.92 million, a price-to-earnings ratio of -0.54 and a beta of 0.07. The company’s 50 day simple moving average is $0.49 and its 200 day simple moving average is $0.67. Applied DNA Sciences has a 52 week low of $0.28 and a 52 week high of $1.86.
Applied DNA Sciences (NASDAQ:APDN – Get Free Report) last released its quarterly earnings results on Thursday, February 8th. The technology company reported ($0.09) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.31) by $0.22. The business had revenue of $0.89 million for the quarter, compared to the consensus estimate of $0.70 million. Applied DNA Sciences had a negative net margin of 80.14% and a negative return on equity of 159.93%. As a group, equities research analysts predict that Applied DNA Sciences will post -0.63 earnings per share for the current year.
Analysts Set New Price Targets
View Our Latest Report on APDN
Institutional Investors Weigh In On Applied DNA Sciences
An institutional investor recently bought a new position in Applied DNA Sciences stock. Silverberg Bernstein Capital Management LLC acquired a new stake in shares of Applied DNA Sciences, Inc. (NASDAQ:APDN – Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 98,301 shares of the technology company’s stock, valued at approximately $61,000. Silverberg Bernstein Capital Management LLC owned 0.72% of Applied DNA Sciences as of its most recent filing with the Securities & Exchange Commission. 22.22% of the stock is currently owned by institutional investors.
Applied DNA Sciences Company Profile
Applied DNA Sciences, Inc, a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services.
Further Reading
- Five stocks we like better than Applied DNA Sciences
- The Role Economic Reports Play in a Successful Investment Strategy
- Charles Schwab Fortifies its Uptrend on EPS Beat
- How Technical Indicators Can Help You Find Oversold Stocks
- Lockheed Martin Stock Aims for a Fresh All-Time High
- What is a Dividend King?
- Beyond the Halving: The Future of Bitcoin Mining Stocks
Receive News & Ratings for Applied DNA Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Applied DNA Sciences and related companies with MarketBeat.com's FREE daily email newsletter.